Metabolic
Metabolic research peptides in Canada: Tirzepatide and Retatrutide for in-vitro incretin (GLP-1/GIP) receptor study. Janoshik-verified, COA on request.
The Metabolic category groups research peptides used to study incretin signalling and energy-metabolism pathways in controlled in-vitro and benchtop settings. These reference materials are of interest to investigators characterizing the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptor families, along with the downstream cAMP and receptor-binding assays used to profile agonist activity, receptor selectivity, and structure-activity relationships at the molecular level.
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied as a reference compound for co-agonism, comparative binding affinity, and receptor-desensitization experiments. Retatrutide is a triple agonist engaging GIP, GLP-1, and glucagon receptors, used in vitro to model multi-receptor pharmacology and signalling crosstalk. Both are supplied strictly as laboratory reference standards for research use only, not for human or animal use. Every lot is third-party verified by Janoshik Analytical using HPLC and mass spectrometry, with a batch-specific Certificate of Analysis available on request. Orders ship with fast, discreet Canadian dispatch from Vancouver via Canada Post Xpresspost, priced in CAD.